Destina Genomics is a biotech company offering nucleic acid testing and molecular diagnostics assays solutions. It develops technologies for detecting nucleic acids and their mutations as well as direct detection and absolute quantification of miRNAs from body fluids. Additionally, the company provides a spin-tube device and liquid biopsy assay kits.